(Q36968260)

17 August 2017

1 reference

title

Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations (English)

1 reference

17 August 2017

0 references

Christian Moser

1

1 reference

17 August 2017

Mario Amacker

2

1 reference

17 August 2017

Andreas R Kammer

3

1 reference

17 August 2017

Silvia Rasi

4

1 reference

17 August 2017

Nicole Westerfeld

5

1 reference

17 August 2017

Rinaldo Zurbriggen

6

1 reference

17 August 2017

publication date

1 October 2007

1 reference

Expert Review of Vaccines

17 August 2017

published in

1 reference

17 August 2017

volume

6

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

711-721

1 reference

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Regulatory considerations on new adjuvants and delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Immunological concepts of vaccine adjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Novel approaches to vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Replication of Rous sarcoma virus and the biosynthesis of the oncogenic subviral ribonucleoprotein particles ("virosomes") in the mitochondria isolated from Rous sarcoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Formation of virosomes from influenza subunits and liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Effective subunit vaccines against an enveloped animal virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Virus-like particles: passport to immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Virus-like particles as immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

21 January 2018

Antigen delivery systems

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Applications of influenza virosomes as a delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Virosomes for antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

The virosome concept for influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Virosomal adjuvanted antigen delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Immunostimulating reconstituted influenza virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Virosomes as new carrier system for cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Clinical applications of virosomes in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Perspectives: towards a peptide-based vaccine against hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Peptides delivered by immunostimulating reconstituted influenza virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Influenza virosomes as an efficient system for adjuvanted vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Use of resonance energy transfer to monitor membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Fluorescent lipid probes in the study of viral membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Evaluation of viral membrane fusion assays. Comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

The role of antibody concentration and avidity in antiviral protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

A virosome-mimotope approach to synthetic vaccine design and optimization: synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Viral recognition by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

High prevalence of influenza specific antibody secreting cells in nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Inflexal V--the influenza vaccine with the lowest ovalbumin content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

Efficient delivery of DNA to dendritic cells mediated by influenza virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.711

21 January 2018

Identifiers

DOI

10.1586/14760584.6.5.711

1 reference

17 August 2017

1 reference